TABLE 4.
Antimicrobial resistance patterns among Vibrio parahaemolyticus strains isolated during the oyster relaying process
| Antibiotic | % with profilea: |
||
|---|---|---|---|
| S | I | R | |
| Amikacinb | 96 | 3 | 1 |
| Amoxicillin-clavulanic acid | 99 | 0 | 1 |
| Ampicillin | 91 | 5 | 3 |
| Ampicillin-sulbactam | 100 | 0 | 0 |
| Cefepime | 95 | 4 | 1 |
| Cefotaximeb | 97 | 0 | 3 |
| Cefoxitin | 92 | 25 | 13 |
| Ceftazidimeb | 87 | 4 | 7 |
| Ceftriaxoneb | 90 | 4 | 5 |
| Cephalothin | 41 | 48 | 11 |
| Chloramphenicol | 99 | 1 | 0 |
| Ciprofloxacinb | 100 | 0 | 0 |
| Doxycyclineb | 98 | 1 | 1 |
| Imipenem | 97 | 3 | 0 |
| Levofloxacinb | 100 | 0 | 0 |
| Meropenem | 98 | 2 | 0 |
| Piperacillin | 98 | 1 | 1 |
| Piperacillin-tazobactam | 100 | 0 | 0 |
| Tetracyclineb | 99 | 0 | 1 |
| Trimethoprim-sulfamethoxazoleb | 100 | 0 | 0 |
a
S, susceptible; I, intermediate; R, resistant.
b
CDC-recommended antibiotic for Vibrio infections.